nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.134	0.198	CbGbCtD
Cilostazol—CYP3A7—Ifosfamide—testicular cancer	0.134	0.198	CbGbCtD
Cilostazol—CYP3A5—Ifosfamide—testicular cancer	0.101	0.148	CbGbCtD
Cilostazol—CYP2C19—Ifosfamide—testicular cancer	0.0813	0.12	CbGbCtD
Cilostazol—CYP3A5—Etoposide—testicular cancer	0.0482	0.0709	CbGbCtD
Cilostazol—CYP3A4—Ifosfamide—testicular cancer	0.0393	0.0578	CbGbCtD
Cilostazol—CYP1A2—Etoposide—testicular cancer	0.0359	0.0528	CbGbCtD
Cilostazol—CYP2D6—Vinblastine—testicular cancer	0.0328	0.0482	CbGbCtD
Cilostazol—CYP3A4—Vinblastine—testicular cancer	0.0209	0.0307	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—testicular cancer	0.0202	0.0296	CbGbCtD
Cilostazol—CYP3A4—Etoposide—testicular cancer	0.0188	0.0276	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—testicular cancer	0.0128	0.0189	CbGbCtD
Cilostazol—Hypotension—Etoposide—testicular cancer	0.000295	0.00092	CcSEcCtD
Cilostazol—Rash—Bleomycin—testicular cancer	0.000294	0.00092	CcSEcCtD
Cilostazol—Gastritis—Doxorubicin—testicular cancer	0.000294	0.000919	CcSEcCtD
Cilostazol—Pain—Cisplatin—testicular cancer	0.000294	0.000919	CcSEcCtD
Cilostazol—Dermatitis—Bleomycin—testicular cancer	0.000294	0.000919	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000293	0.000917	CcSEcCtD
Cilostazol—Conjunctivitis—Methotrexate—testicular cancer	0.000288	0.000899	CcSEcCtD
Cilostazol—Influenza—Doxorubicin—testicular cancer	0.000287	0.000898	CcSEcCtD
Cilostazol—Asthma—Doxorubicin—testicular cancer	0.000287	0.000898	CcSEcCtD
Cilostazol—Pollakiuria—Epirubicin—testicular cancer	0.000287	0.000897	CcSEcCtD
Cilostazol—Asthenia—Ifosfamide—testicular cancer	0.000286	0.000894	CcSEcCtD
Cilostazol—Feeling abnormal—Cisplatin—testicular cancer	0.000284	0.000886	CcSEcCtD
Cilostazol—Paraesthesia—Etoposide—testicular cancer	0.000283	0.000884	CcSEcCtD
Cilostazol—Pruritus—Ifosfamide—testicular cancer	0.000282	0.000882	CcSEcCtD
Cilostazol—Haematuria—Methotrexate—testicular cancer	0.000282	0.000882	CcSEcCtD
Cilostazol—Dyspnoea—Etoposide—testicular cancer	0.000281	0.000878	CcSEcCtD
Cilostazol—Angina pectoris—Doxorubicin—testicular cancer	0.00028	0.000875	CcSEcCtD
Cilostazol—Hepatobiliary disease—Methotrexate—testicular cancer	0.00028	0.000875	CcSEcCtD
Cilostazol—Epistaxis—Methotrexate—testicular cancer	0.000279	0.000872	CcSEcCtD
Cilostazol—Pneumonia—Epirubicin—testicular cancer	0.000279	0.00087	CcSEcCtD
Cilostazol—Nausea—Bleomycin—testicular cancer	0.000277	0.000866	CcSEcCtD
Cilostazol—Vomiting—Dactinomycin—testicular cancer	0.000277	0.000865	CcSEcCtD
Cilostazol—Bronchitis—Doxorubicin—testicular cancer	0.000276	0.000864	CcSEcCtD
Cilostazol—Agranulocytosis—Methotrexate—testicular cancer	0.000276	0.000863	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000275	0.000858	CcSEcCtD
Cilostazol—Rash—Dactinomycin—testicular cancer	0.000275	0.000858	CcSEcCtD
Cilostazol—Decreased appetite—Etoposide—testicular cancer	0.000274	0.000856	CcSEcCtD
Cilostazol—Diarrhoea—Ifosfamide—testicular cancer	0.000273	0.000853	CcSEcCtD
Cilostazol—Pancytopenia—Doxorubicin—testicular cancer	0.000273	0.000853	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Etoposide—testicular cancer	0.000272	0.00085	CcSEcCtD
Cilostazol—Body temperature increased—Cisplatin—testicular cancer	0.000272	0.00085	CcSEcCtD
Cilostazol—Jaundice—Epirubicin—testicular cancer	0.00027	0.000843	CcSEcCtD
Cilostazol—Pain—Etoposide—testicular cancer	0.00027	0.000842	CcSEcCtD
Cilostazol—Urinary tract infection—Epirubicin—testicular cancer	0.000269	0.000841	CcSEcCtD
Cilostazol—Conjunctivitis—Epirubicin—testicular cancer	0.000269	0.000841	CcSEcCtD
Cilostazol—Haemoglobin—Methotrexate—testicular cancer	0.000267	0.000834	CcSEcCtD
Cilostazol—Haemorrhage—Methotrexate—testicular cancer	0.000266	0.00083	CcSEcCtD
Cilostazol—Pollakiuria—Doxorubicin—testicular cancer	0.000266	0.00083	CcSEcCtD
Cilostazol—Haematuria—Epirubicin—testicular cancer	0.000264	0.000825	CcSEcCtD
Cilostazol—Dizziness—Ifosfamide—testicular cancer	0.000264	0.000824	CcSEcCtD
Cilostazol—Pharyngitis—Methotrexate—testicular cancer	0.000264	0.000824	CcSEcCtD
Cilostazol—Hepatobiliary disease—Epirubicin—testicular cancer	0.000262	0.000818	CcSEcCtD
Cilostazol—Epistaxis—Epirubicin—testicular cancer	0.000261	0.000816	CcSEcCtD
Cilostazol—Sinusitis—Epirubicin—testicular cancer	0.00026	0.000812	CcSEcCtD
Cilostazol—Feeling abnormal—Etoposide—testicular cancer	0.00026	0.000811	CcSEcCtD
Cilostazol—Nausea—Dactinomycin—testicular cancer	0.000259	0.000808	CcSEcCtD
Cilostazol—Agranulocytosis—Epirubicin—testicular cancer	0.000259	0.000808	CcSEcCtD
Cilostazol—Pneumonia—Doxorubicin—testicular cancer	0.000258	0.000805	CcSEcCtD
Cilostazol—Gastrointestinal pain—Etoposide—testicular cancer	0.000258	0.000805	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000254	0.000794	CcSEcCtD
Cilostazol—Vomiting—Ifosfamide—testicular cancer	0.000254	0.000793	CcSEcCtD
Cilostazol—Rash—Ifosfamide—testicular cancer	0.000252	0.000786	CcSEcCtD
Cilostazol—Dermatitis—Ifosfamide—testicular cancer	0.000251	0.000785	CcSEcCtD
Cilostazol—Erythema multiforme—Methotrexate—testicular cancer	0.000251	0.000785	CcSEcCtD
Cilostazol—Urticaria—Etoposide—testicular cancer	0.00025	0.000782	CcSEcCtD
Cilostazol—Haemoglobin—Epirubicin—testicular cancer	0.00025	0.000781	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—testicular cancer	0.00025	0.00078	CcSEcCtD
Cilostazol—Rhinitis—Epirubicin—testicular cancer	0.000249	0.000779	CcSEcCtD
Cilostazol—Abdominal pain—Etoposide—testicular cancer	0.000249	0.000778	CcSEcCtD
Cilostazol—Body temperature increased—Etoposide—testicular cancer	0.000249	0.000778	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—testicular cancer	0.000249	0.000778	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—testicular cancer	0.000249	0.000778	CcSEcCtD
Cilostazol—Haemorrhage—Epirubicin—testicular cancer	0.000249	0.000777	CcSEcCtD
Cilostazol—Tinnitus—Methotrexate—testicular cancer	0.000248	0.000774	CcSEcCtD
Cilostazol—Hypoaesthesia—Epirubicin—testicular cancer	0.000247	0.000773	CcSEcCtD
Cilostazol—Asthenia—Cisplatin—testicular cancer	0.000247	0.000771	CcSEcCtD
Cilostazol—Pharyngitis—Epirubicin—testicular cancer	0.000247	0.000771	CcSEcCtD
Cilostazol—Cardiac disorder—Methotrexate—testicular cancer	0.000247	0.00077	CcSEcCtD
Cilostazol—Oedema peripheral—Epirubicin—testicular cancer	0.000245	0.000765	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—testicular cancer	0.000244	0.000763	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000242	0.000757	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—testicular cancer	0.000242	0.000755	CcSEcCtD
Cilostazol—Angiopathy—Methotrexate—testicular cancer	0.000241	0.000753	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—testicular cancer	0.00024	0.000751	CcSEcCtD
Cilostazol—Mediastinal disorder—Methotrexate—testicular cancer	0.000239	0.000748	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—testicular cancer	0.000239	0.000747	CcSEcCtD
Cilostazol—Chills—Methotrexate—testicular cancer	0.000238	0.000745	CcSEcCtD
Cilostazol—Nausea—Ifosfamide—testicular cancer	0.000237	0.00074	CcSEcCtD
Cilostazol—Diarrhoea—Cisplatin—testicular cancer	0.000235	0.000735	CcSEcCtD
Cilostazol—Erythema multiforme—Epirubicin—testicular cancer	0.000235	0.000734	CcSEcCtD
Cilostazol—Tinnitus—Epirubicin—testicular cancer	0.000232	0.000724	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—testicular cancer	0.000231	0.000722	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—testicular cancer	0.000231	0.000721	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—testicular cancer	0.000231	0.000721	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—testicular cancer	0.00023	0.000719	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—testicular cancer	0.000229	0.000715	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—testicular cancer	0.000228	0.000713	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—testicular cancer	0.000227	0.000708	CcSEcCtD
Cilostazol—Asthenia—Etoposide—testicular cancer	0.000226	0.000706	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—testicular cancer	0.000226	0.000705	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—testicular cancer	0.000224	0.0007	CcSEcCtD
Cilostazol—Back pain—Methotrexate—testicular cancer	0.000224	0.000699	CcSEcCtD
Cilostazol—Chills—Epirubicin—testicular cancer	0.000223	0.000697	CcSEcCtD
Cilostazol—Pruritus—Etoposide—testicular cancer	0.000223	0.000697	CcSEcCtD
Cilostazol—Vomiting—Cisplatin—testicular cancer	0.000219	0.000683	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—testicular cancer	0.000218	0.00068	CcSEcCtD
Cilostazol—Rash—Cisplatin—testicular cancer	0.000217	0.000678	CcSEcCtD
Cilostazol—Dermatitis—Cisplatin—testicular cancer	0.000217	0.000677	CcSEcCtD
Cilostazol—Diarrhoea—Etoposide—testicular cancer	0.000216	0.000674	CcSEcCtD
Cilostazol—Ill-defined disorder—Methotrexate—testicular cancer	0.000215	0.00067	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—testicular cancer	0.000215	0.00067	CcSEcCtD
Cilostazol—Anaemia—Methotrexate—testicular cancer	0.000214	0.000668	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—testicular cancer	0.000214	0.000667	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—testicular cancer	0.000213	0.000666	CcSEcCtD
Cilostazol—Back pain—Epirubicin—testicular cancer	0.000209	0.000654	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—testicular cancer	0.000209	0.000652	CcSEcCtD
Cilostazol—Malaise—Methotrexate—testicular cancer	0.000209	0.000652	CcSEcCtD
Cilostazol—Dizziness—Etoposide—testicular cancer	0.000208	0.000651	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—testicular cancer	0.000208	0.00065	CcSEcCtD
Cilostazol—Vertigo—Methotrexate—testicular cancer	0.000208	0.000649	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000207	0.000648	CcSEcCtD
Cilostazol—Leukopenia—Methotrexate—testicular cancer	0.000207	0.000647	CcSEcCtD
Cilostazol—Chills—Doxorubicin—testicular cancer	0.000206	0.000645	CcSEcCtD
Cilostazol—Nausea—Cisplatin—testicular cancer	0.000204	0.000638	CcSEcCtD
Cilostazol—Cough—Methotrexate—testicular cancer	0.000202	0.000631	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—testicular cancer	0.000201	0.000627	CcSEcCtD
Cilostazol—Vomiting—Etoposide—testicular cancer	0.0002	0.000626	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—testicular cancer	0.0002	0.000625	CcSEcCtD
Cilostazol—Rash—Etoposide—testicular cancer	0.000199	0.000621	CcSEcCtD
Cilostazol—Dermatitis—Etoposide—testicular cancer	0.000199	0.00062	CcSEcCtD
Cilostazol—Headache—Etoposide—testicular cancer	0.000197	0.000617	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—testicular cancer	0.000197	0.000617	CcSEcCtD
Cilostazol—Myalgia—Methotrexate—testicular cancer	0.000197	0.000615	CcSEcCtD
Cilostazol—Arthralgia—Methotrexate—testicular cancer	0.000197	0.000615	CcSEcCtD
Cilostazol—Chest pain—Methotrexate—testicular cancer	0.000197	0.000615	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000196	0.000611	CcSEcCtD
Cilostazol—Malaise—Epirubicin—testicular cancer	0.000195	0.00061	CcSEcCtD
Cilostazol—Discomfort—Methotrexate—testicular cancer	0.000195	0.000608	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—testicular cancer	0.000194	0.000608	CcSEcCtD
Cilostazol—Syncope—Epirubicin—testicular cancer	0.000194	0.000606	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—testicular cancer	0.000194	0.000605	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—testicular cancer	0.000194	0.000605	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—testicular cancer	0.000193	0.000602	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—testicular cancer	0.000191	0.000598	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—testicular cancer	0.00019	0.000594	CcSEcCtD
Cilostazol—Cough—Epirubicin—testicular cancer	0.000189	0.00059	CcSEcCtD
Cilostazol—Infection—Methotrexate—testicular cancer	0.000188	0.000586	CcSEcCtD
Cilostazol—Nausea—Etoposide—testicular cancer	0.000187	0.000585	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—testicular cancer	0.000187	0.000584	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—testicular cancer	0.000186	0.000581	CcSEcCtD
Cilostazol—Nervous system disorder—Methotrexate—testicular cancer	0.000185	0.000578	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—testicular cancer	0.000185	0.000578	CcSEcCtD
Cilostazol—Thrombocytopenia—Methotrexate—testicular cancer	0.000185	0.000577	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—testicular cancer	0.000184	0.000576	CcSEcCtD
Cilostazol—Arthralgia—Epirubicin—testicular cancer	0.000184	0.000576	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—testicular cancer	0.000184	0.000576	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—testicular cancer	0.000184	0.000574	CcSEcCtD
Cilostazol—Skin disorder—Methotrexate—testicular cancer	0.000183	0.000573	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000183	0.000572	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—testicular cancer	0.000182	0.000569	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—testicular cancer	0.000181	0.000564	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—testicular cancer	0.00018	0.000562	CcSEcCtD
Cilostazol—Anorexia—Methotrexate—testicular cancer	0.00018	0.000562	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—testicular cancer	0.00018	0.000561	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—testicular cancer	0.000179	0.00056	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—testicular cancer	0.000177	0.000553	CcSEcCtD
Cilostazol—Oedema—Epirubicin—testicular cancer	0.000177	0.000552	CcSEcCtD
Cilostazol—Hypotension—Methotrexate—testicular cancer	0.000176	0.000551	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—testicular cancer	0.000176	0.00055	CcSEcCtD
Cilostazol—Infection—Epirubicin—testicular cancer	0.000176	0.000548	CcSEcCtD
Cilostazol—Cough—Doxorubicin—testicular cancer	0.000175	0.000546	CcSEcCtD
Cilostazol—Shock—Epirubicin—testicular cancer	0.000174	0.000543	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—testicular cancer	0.000173	0.000541	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—testicular cancer	0.000173	0.00054	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—testicular cancer	0.000173	0.00054	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—testicular cancer	0.000172	0.000539	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000172	0.000537	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—testicular cancer	0.000172	0.000536	CcSEcCtD
Cilostazol—Insomnia—Methotrexate—testicular cancer	0.000171	0.000533	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—testicular cancer	0.000171	0.000533	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—testicular cancer	0.000171	0.000533	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—testicular cancer	0.000171	0.000533	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—testicular cancer	0.00017	0.000531	CcSEcCtD
Cilostazol—Paraesthesia—Methotrexate—testicular cancer	0.00017	0.00053	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000169	0.000529	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—testicular cancer	0.000168	0.000526	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—testicular cancer	0.000168	0.000526	CcSEcCtD
Cilostazol—Dyspnoea—Methotrexate—testicular cancer	0.000168	0.000526	CcSEcCtD
Cilostazol—Dyspepsia—Methotrexate—testicular cancer	0.000166	0.000519	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—testicular cancer	0.000165	0.000516	CcSEcCtD
Cilostazol—Decreased appetite—Methotrexate—testicular cancer	0.000164	0.000513	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—testicular cancer	0.000163	0.000511	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000163	0.000509	CcSEcCtD
Cilostazol—Infection—Doxorubicin—testicular cancer	0.000162	0.000507	CcSEcCtD
Cilostazol—Pain—Methotrexate—testicular cancer	0.000161	0.000504	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000161	0.000503	CcSEcCtD
Cilostazol—Shock—Doxorubicin—testicular cancer	0.000161	0.000502	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—testicular cancer	0.00016	0.000501	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—testicular cancer	0.00016	0.0005	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—testicular cancer	0.00016	0.000499	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—testicular cancer	0.00016	0.000498	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—testicular cancer	0.000159	0.000496	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—testicular cancer	0.000159	0.000496	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—testicular cancer	0.000158	0.000492	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—testicular cancer	0.000156	0.000487	CcSEcCtD
Cilostazol—Feeling abnormal—Methotrexate—testicular cancer	0.000156	0.000486	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—testicular cancer	0.000156	0.000486	CcSEcCtD
Cilostazol—Gastrointestinal pain—Methotrexate—testicular cancer	0.000154	0.000482	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—testicular cancer	0.000154	0.00048	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—testicular cancer	0.000153	0.000477	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000153	0.000476	CcSEcCtD
Cilostazol—Pain—Epirubicin—testicular cancer	0.000151	0.000472	CcSEcCtD
Cilostazol—Urticaria—Methotrexate—testicular cancer	0.00015	0.000468	CcSEcCtD
Cilostazol—Abdominal pain—Methotrexate—testicular cancer	0.000149	0.000466	CcSEcCtD
Cilostazol—Body temperature increased—Methotrexate—testicular cancer	0.000149	0.000466	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000149	0.000465	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—testicular cancer	0.000148	0.000462	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—testicular cancer	0.000147	0.000459	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—testicular cancer	0.000146	0.000455	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—testicular cancer	0.000146	0.000455	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000144	0.000451	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—testicular cancer	0.000144	0.00045	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—testicular cancer	0.000142	0.000444	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000141	0.000441	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—testicular cancer	0.00014	0.000438	CcSEcCtD
Cilostazol—Pain—Doxorubicin—testicular cancer	0.00014	0.000437	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—testicular cancer	0.00014	0.000436	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—testicular cancer	0.00014	0.000436	CcSEcCtD
Cilostazol—Asthenia—Methotrexate—testicular cancer	0.000135	0.000423	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—testicular cancer	0.000135	0.000421	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000134	0.000418	CcSEcCtD
Cilostazol—Pruritus—Methotrexate—testicular cancer	0.000134	0.000417	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—testicular cancer	0.00013	0.000406	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—testicular cancer	0.000129	0.000404	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—testicular cancer	0.000129	0.000404	CcSEcCtD
Cilostazol—Diarrhoea—Methotrexate—testicular cancer	0.000129	0.000404	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—testicular cancer	0.000127	0.000396	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—testicular cancer	0.000125	0.00039	CcSEcCtD
Cilostazol—Dizziness—Methotrexate—testicular cancer	0.000125	0.00039	CcSEcCtD
Cilostazol—Diarrhoea—Epirubicin—testicular cancer	0.000121	0.000378	CcSEcCtD
Cilostazol—Vomiting—Methotrexate—testicular cancer	0.00012	0.000375	CcSEcCtD
Cilostazol—Rash—Methotrexate—testicular cancer	0.000119	0.000372	CcSEcCtD
Cilostazol—Dermatitis—Methotrexate—testicular cancer	0.000119	0.000371	CcSEcCtD
Cilostazol—Headache—Methotrexate—testicular cancer	0.000118	0.000369	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—testicular cancer	0.000117	0.000366	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—testicular cancer	0.000117	0.000365	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—testicular cancer	0.000116	0.000361	CcSEcCtD
Cilostazol—Vomiting—Epirubicin—testicular cancer	0.000112	0.000351	CcSEcCtD
Cilostazol—Nausea—Methotrexate—testicular cancer	0.000112	0.00035	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—testicular cancer	0.000112	0.000349	CcSEcCtD
Cilostazol—Rash—Epirubicin—testicular cancer	0.000111	0.000348	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—testicular cancer	0.000111	0.000348	CcSEcCtD
Cilostazol—Headache—Epirubicin—testicular cancer	0.000111	0.000346	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—testicular cancer	0.000108	0.000338	CcSEcCtD
Cilostazol—Nausea—Epirubicin—testicular cancer	0.000105	0.000328	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—testicular cancer	0.000104	0.000325	CcSEcCtD
Cilostazol—Rash—Doxorubicin—testicular cancer	0.000103	0.000322	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—testicular cancer	0.000103	0.000322	CcSEcCtD
Cilostazol—Headache—Doxorubicin—testicular cancer	0.000102	0.00032	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—testicular cancer	9.71e-05	0.000303	CcSEcCtD
